Systematic review and meta-analysis of randomized clinical trials (RCTs) comparing topical calcineurin inhibitors with topical corticosteroids for atopic dermatitis: a 15-year …

High Impact Factor (IF > 5) — 16 citations

1. V Prasannanjaneyulu, S Nene, H Jain…. Old drugs, new tricks: Emerging role of drug repurposing in the management of atopic dermatitis. Cytokine & growth factor …. 2022. doi:10.1016/j.cytogfr.2022.04.007 PMID:35550114.

   IF 11.8PDF
2. J Pena, PA Zameza, JN Pixley, A Remitz…. A comparison of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis. The Journal of Allergy …. 2023. doi:10.1016/j.jaip.2023.03.022 PMID:36997119.

   IF 11.2PDF
3. M Boguniewicz, L Fonacier, DYM Leung. Atopic and contact dermatitis. Clinical Immunology. 2019. doi:10.1111/j.1600-0536.1980.tb03886.x.

   IF 11.2
4. C Sibbald. Dupilumab in adolescent atopic dermatitis: interpreting the data.. British Journal of Dermatology. 2020.

   IF 10.6PDF
5. MC Chen, CS Chen, YW Wu, YY Yang. Poly-γ-Glutamate microneedles as transdermal immunomodulators for ameliorating atopic dermatitis-like skin lesions in Nc/Nga mice. Acta Biomaterialia. 2020. doi:10.1016/j.actbio.2020.07.029 PMID:32688089.

   IF 9.6PDF
6. SJ Lax, E Van Vogt, B Candy, L Steele…. Topical anti‐inflammatory treatments for eczema: network meta‐analysis. Cochrane Database …. 2024. doi:10.1002/14651858.cd015064.

   IF 9.4PDF
7. E Axon, L Howells, M Santer, MJ Ridd…. Strategies for using topical corticosteroids in children and adults with eczema. Cochrane Database …. 2022. doi:10.1016/j.fander.2023.12.005.

   IF 9.4PDF
8. JR Chalmers, E Axon, J Harvey…. Different strategies for using topical corticosteroids in people with eczema. The Cochrane …. 2019. doi:10.1002/14651858.cd013356.

   IF 9.4PDF
9. MH Napimoga…. The 15d-PGJ2 hydrogel ameliorates atopic dermatitis through suppression of the immune response. Molecular …. 2019. doi:10.3892/mmr.2019.10156 PMID:31059034.

   IF 6.4PDF
10. D Li, Y Han, J Zhou, J Chen, HL Tey…. Flavonoids in atopic dermatitis: mechanisms, delivery innovations, and translational strategies. Frontiers in …. 2025. doi:10.3389/fphar.2025.1631977 PMID:40918538.

    IF 5.9PDF
11. AY Binsaleh, MM Bahaa, TA Elmasry, EI Elberri…. A randomized controlled trial comparing tacrolimus versus hydrocortisone for the treatment of atopic dermatitis in children: New perspectives on interferon gamma …. Frontiers in …. 2024. doi:10.3389/fmed.2024.1399305 PMID:39114823.

    IF 5.9PDF
12. JY Shin, DN Che, JH Park, BO Cho, SI Jang. Isochlorogenic acid A ameliorates atopic dermatitis by modulating JAK/STAT3, NF-κB, and MAPK pathways in a DNFB/PM2. 5-induced mouse model. International …. 2026.

    IF 5.8PDF
13. YL Chen, CC Chang, YC Lin, MC Chen. Double-layered PLGA/HA microneedle systems as a long-acting formulation of polyphenols for effective and long-term management of atopic dermatitis. Biomaterials science. 2023. doi:10.1039/d3bm00182b PMID:37334517.

    IF 5.7PDF
14. LR Lorz, D Kim, MY Kim, JY Cho. Panax ginseng–derived fraction BIOGF1K reduces atopic dermatitis responses via suppression of mitogen-activated protein kinase signaling pathway. Journal of Ginseng Research. 2020. doi:10.1016/j.jgr.2019.02.003 PMID:32372867.

    IF 5.6PDF
15. R Meher, A Mishra, A Srinivasan, R Maiti, D Hota. Efficacy and safety of tapinarof in atopic dermatitis: a frequentist and bayesian meta-analysis of randomized controlled trials. Inflammopharmacology. 2026. doi:10.1007/s10787-025-02087-0.

    IF 5.3PDF
16. B Gundogan, N Dowlut, S Rajmohan, MR Borrelli…. Assessing the compliance of systematic review articles published in leading dermatology journals with the PRISMA statement guidelines: A systematic review. JAAD international. 2020. doi:10.1016/j.jdin.2020.07.007 PMID:34409336.

    IF 5.2PDF